NeurologyLive®

🚀 Big news: The new NeurologyLive website is here! Enjoy faster browsing, streamlined access, and bite-sized shorts to stay on top of neurology updates. Explore the upgrade today: hubs.li/Q03KD_GC0

🧠 💙 Our last interview for Day 2 of #CMSC26 was with Elizabeth S. Gromisch, MD, MSCS, of @THOfNewEngland, who spoke with us about her presentation on cognitive screening in MS! Stay tuned for the conversation! 🗣 📹 @mscare @IJMSCtweets

📹 🧠 This afternoon for Day 2 of #CMSC26, we spoke with experts @MSDoc_Freedman, and @ahmedzobeidat, who spoke with us about the future of clinical trials in MS! Be on the lookout for these conversations coming soon to our site! 🥼⚕️@mscare

Day 2⃣ at #CMSC2026 is underway‼️ We got a sneak peek at the poster hall ahead of today’s 5 PM opening. Be sure to visit neurologylive.com/conferences/cm… to receive all of our latest updates from the meeting. The 40th annual @mscare meeting has been incredibly insightful so far! #MS #Neurology #BrainHealth

We'll continue to cover the 2026 @mscare Annual Meeting in Charlotte, NC, for the next few days. In the meantime, here's a look at some of our early content from the conference: 💊 GLP-1 Receptor Agonists Linked to Improved Physical Activity in Multiple Sclerosis - neurologylive.com/view/glp-1-rec… 📊 Three-Year Extension Findings Reinforce Frexalimab’s Safety and Efficacy in Relapsing MS - neurologylive.com/view/three-yea… 📰 Complement Inhibition May Stabilize AQP4-Positive NMOSD After Inebilizumab Failure, Analysis Suggests - neurologylive.com/view/complemen… ✍ Phase 4 Study Reports Improved Patient-Reported Outcomes With Ublituximab in Multiple Sclerosis - neurologylive.com/view/phase-4-s… 🧠 Ozanimod Preserves Multiple Sclerosis Cognition in New 3-Year Analysis - neurologylive.com/view/ozanimod-…

The #CMSC2026 annual meeting marks the 40th gathering❗ Dating back to 1986, @mscare has remained at the forefront of fostering clinical collaboration, driving innovation in the MS field, and educating the future of neurology specialists View our coverage here 👇neurologylive.com/conferences/cm… #Neurology #BrainHealth #ClinicalConference

#CMSC2026 Day 2!

🧠🗣 Our first interview for Day 2 of #CMSC26 was with John Corboy, MD, of @CUAnschutz, who spoke about his presentation on DMT discontinuation in MS! Stay tuned! 💊🎙 @mscare

New Mind Moments episode drops tomorrow 🎙️💤 Dr. Todd Arnedt, PhD, of @umichmedicine, joins us to break down the newly published @AASMorg clinical practice guideline on combination treatment for chronic insomnia disorder in adults. The episode explores: 🛌 CBT-I and pharmacotherapy approaches 📊 Evidence behind combination treatment 🧠 Patient-specific treatment considerations 🔍 Key research gaps still facing insomnia care Stay tuned for the full episode tomorrow! For all Mind Moments eps: neurologylive.com/podcasts Spotify: open.spotify.com/show/65aALs6Pc…

🌞☕️ Good morning! It is Day 2 of #CMSC26! We have another great lineup of interviews with experts in MS for today. Stay tuned! 🧠🗣 @mscare

Libby Levine, MSN, compares the definitions of obesity and MS. Similar adjectives are used: chronic, relapsing, multifactorial. In the era of GLP1s, patients themselves are bringing up weight in appointments. #CMSC2026

🌟🧠 Earlier today at #CMSC26, we had the pleasure of speaking with patient advocate, Jamie Lynn Sigler, who shared her story of living with multiple sclerosis! Stay tuned for this interview! 🗣🎙@mscare

🧠 At the 2026 CMSC Annual Meeting (@mscare), NeurologyLive caught up with Cecilia Meza, MA, to discuss recent research involving RehaCom rehabilitation Meza, a clinical research coordinator at Sunnybrook Hospital and St. Michael's Hopsital, spoke about the differnt arms of the CogEx trial 🦾 Here’s what she had to say about the control group in the trial 👀 #CMSC2026

📹 🧠 One of our last interviews for Day 1 of #CMSC26 was with Kristen Krysko, MD, of @UnityHealthTO, who shared the main takeaways from her presentation on pregnancy and ocrelizumab in women with MS. @mscare🤰💊

Full house for GLP-1s and #MultipleSclerosis. #CMSC2026

With day 1⃣ of #CMSC2026 (@mscare) coming to a close, there is still so much ahead for the rest of the conference. What are you most looking forward to over the next 2 days? Vote below 🗳️

💊 🧠 This afternoon at #CMSC26, we spoke with Amy Gutierrez, MD, of @orlandohealth, about her presentation on a subgroup analysis of cladribine tablets in older patients with MS! Be on the lookout for the conversation soon! @mscare